This is the authors' abstract. We don't add key points for this paper.
Sir, We have served as members of the Renal Safety Board for deferasirox (Exjade®, ICL670) for the past 5 years and wish to respond to a misleading comment on the renal safety profile of deferasirox that appears in the discussion section of a recent article by Clajus et al . [ 1 ], which describes a case report of acute kidney injury due to deferoxamine. The authors state that deferasirox has ‘been repeatedly shown to cause acute renal failure’, citing a recent article by Kontoghiorghes [ 2 ]. It should be pointed out that Kontoghiorghes bases many of his conclusions about the tolerability of deferasirox on post-marketing surveillance information. Such events are reported in the drug label irrespective of whether a causal link has been established. More than 30 000 patients have been treated with deferasirox outside the clinical trial setting, many of whom were elderly or had other underlying medical conditions in addition to transfusional iron overload. Although acute renal failure was reported in a very small number of patients receiving deferasirox, almost all of these patients had severe complications of their underlying haematological disease, most commonly sepsis, and the contribution of deferasirox to the renal insufficiency in these critically ill patients is quite uncertain. Having reviewed many of these cases in detail, we are very skeptical that deferasirox was responsible for the episodes of renal failure. In addition, the term ‘acute renal failure’ was probably used inappropriately in many cases to describe relatively minor increases in serum creatinine (<2 × upper limit of normal) that developed over the course of several weeks. Conflict of interest statement . C.P. is a consultant of Novartis, Italy, for transplantation and autoimmune diseases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hirschberg et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: